CP

Cyriac Pappachan

Active Director Director DIN 07904064
DIN 07904064 First appointment Aug 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Aug 2017
Shareholding value •••• Premium profile

About Cyriac Pappachan

Data last updated:

Cyriac Pappachan is a Director at Kcr Pharmaceuticals Private Limited (since 2020), Director at Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited (since 2018) and Whole-Time Director at Adoor Lifeline Medical Solutions Private Limited (since 2017). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹8.36 Cr; the largest is Kcr Pharmaceuticals Private Limited at ₹5.95 Cr (FY 2025). Earlier, Cyriac Pappachan was an Additional Director at Padak Rubbers Private Limited (from 2020).

DIN 07904064
Primary Designation Director
Industry Pharma
First Appointment 16 Aug 2017
Oldest Company Age 14 yrs
Largest company Kcr Pharmaceuticals Private Limited · ₹5.95 Cr (FY 2025)
Combined revenue ₹8.36 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kcr Pharmaceuticals Private Limited U85300KL2020PTC062642
Director01 Jul 20202020₹5.95 Cr (FY 2025)Active
Director02 May 20182012₹2.42 Cr (FY 2025)Active
Whole-Time Director16 Aug 20172017₹3,570 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Padak Rubbers Private Limited U25199KL2020PTC061233
Additional Director02 May 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Padak Rubbers Private Limited
Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited
Kcr Pharmaceuticals Private Limited
Adoor Lifeline Medical Solutions Private Limited
Premium access

Shareholding and investment profile for Cyriac Pappachan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cyriac Pappachan

Cyriac Pappachan currently holds 3 directorships: Kcr Pharmaceuticals Private Limited (Director, since 01 Jul 2020, revenue ₹5.95 Cr (FY 2025)); Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited (Director, since 02 May 2018, revenue ₹2.42 Cr (FY 2025)); Adoor Lifeline Medical Solutions Private Limited (Whole-Time Director, since 16 Aug 2017, revenue ₹3,570 (FY 2024)).

Cyriac Pappachan was first appointed on 16 Aug 2017 as Whole-Time Director at Adoor Lifeline Medical Solutions Private Limited. The most recent appointment on record is 01 Jul 2020 at Kcr Pharmaceuticals Private Limited.

The 3 current companies of Cyriac Pappachan that report revenue have a combined latest revenue of ₹8.36 Cr: Kcr Pharmaceuticals Private Limited ₹5.95 Cr (FY 2025); Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited ₹2.42 Cr (FY 2025); Adoor Lifeline Medical Solutions Private Limited ₹3,570 (FY 2024).

Cyriac Pappachan held 1 earlier board appointment: Padak Rubbers Private Limited (Additional Director, from 02 May 2020).

The current boards of Cyriac Pappachan's companies include Pappachan Skariah Kalayil (Kcr Pharmaceuticals Private Limited), Kripa Rachel Philip (Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited), Mathew Pappachen (Dr.Pappachan's Lifeline Institute Of Medical Science & Research Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available